Marsh & McLennan Companies Inc
NYSE:MMC
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
185.39
231.84
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Earnings Call Analysis
Q3-2024 Analysis
Marsh & McLennan Companies Inc
Marsh McLennan reported a robust performance in Q3, generating $5.7 billion in consolidated revenue, marking a 6% increase from the previous year. Excluding a discrete tax benefit from last year, adjusted EPS rose by 4% to $1.63, reflecting a steady upward trajectory in earnings. The company's adjusted operating income grew by 12%, pushing the adjusted operating margin up by 110 basis points to 22.4%. This marked a continuation of healthy revenue growth across the company, which is particularly notable considering the broader economic uncertainty.
The growth in revenue can be attributed to strong underlying performance in various sectors. Risk and Insurance Services (RIS) achieved an 8% increase in revenue, while Consulting grew by 4%. Marsh, a key business line, reported a 9% increase in revenue, driven by strong retention and new business, indicating healthy market demand. Geographically, burgeoning growth was seen across all regions, especially in Latin America, EMEA, and Asia Pacific—all of which contributed significantly to the overall results. Of note is that Mercer exhibited a consistent performance with a 5% underlying growth, continuing its streak of solid performance across all regions.
Marsh McLennan announced the acquisition of McGriff Insurance Services for $7.75 billion, funded through a mix of cash and debt. This acquisition, expected to close by year-end, is anticipated to be modestly accretive to adjusted EPS in the first year and significantly more so in the second year as synergies are realized. The deal aligns with Marsh McLennan’s strategy to expand into faster-growing markets and enhance its capabilities in the middle market segment. Marking a milestone, this transaction contributes to a more significant M&A strategy with nearly $10 billion committed to acquisitions this year alone.
Looking ahead, leadership expressed optimism about the business trajectory, maintaining expectations for mid-single-digit underlying revenue growth in 2024. The strong performance trend suggests that the company is well-positioned to navigate potentially fluctuating macroeconomic conditions while expanding margins and increasing adjusted EPS. Future guidance includes expectations for adjusted EPS to rise modestly while maintaining an adjusted effective tax rate around 26.5% for next year. Additionally, Marsh McLennan plans to allocate approximately $4.2 billion towards dividends, acquisitions, and share repurchases in 2024, underpinning its commitment to returning capital to shareholders and driving growth.
Despite resilient performance, the company acknowledged various macroeconomic challenges, including geopolitical tensions and rising inflation. Notably, the insurance market is experiencing dynamic shifts, with a decrease in average rates observed in certain segments, while others, such as excess casualty, see robust rate increases. Overall, the management expressed confidence that the company’s strong market position and diversification will help mitigate potential headwinds associated with market fluctuations.
In summary, Marsh McLennan continues to demonstrate its robust business model through consistent revenue growth, strategic acquisitions, and effective capital management. The acquisition of McGriff enhances its market position and aligns with the company's growth strategy. With a strong financial foundation and positive outlook amidst economic uncertainties, Marsh McLennan remains a company to watch for investors looking for stability and growth in the insurance and consulting sectors.
Welcome to Marsh & McLennan's earnings conference call. Today's call is being recorded. Third quarter 2024 financial results and supplemental information were issued earlier this morning. They are available on the company's website at marshmcllennan.com.
Please note that remarks made today may include forward-looking statements. Forward-looking statements are subject to risks and uncertainties, and a variety of factors may cause actual results to differ materially from those contemplated by such statements. For a more detailed discussion of those factors, please refer to our release for this quarter and to our most recent SEC filings, including our most recent Form 10-K, all of which are available on the Marsh McLennan website.
During the call today, we may discuss certain non-GAAP financial measures. For a reconciliation of those measures to the most recently comparable GAAP measures, please refer to the schedule in today's earnings release. [Operator Instructions]
I'll now turn the call over to John Doyle, President and CEO of Marsh & McLennan.
Good morning, and thank you for joining us to discuss our third quarter results reported earlier today. I'm John Doyle, President and CEO of Marsh McLennan. On the call with me is Mark McGivney, our CFO; and the CEOs of our businesses: Martin South of Marsh, Dean Closure of Guy Carpenter; Pat Tomlinson of Mercer; and Nick Studer of Oliver Wyman. .
Also with us this morning for her last quarter as Head of Investor Relations is Sarah DeWitt. We'd like to congratulate Sarah on her new role as Chief Financial Officer of Marsh.
Before I get into our results, I'd like to take a moment to comment on Hurricane Helen and Milton, which have devastated communities in Florida and the Southeast United States. These events are first and foremost, the human tragedy, and our thoughts are with all of those impacted by the storms. Our primary concern has been the well-being of our colleagues and their families as well as our clients and we are actively working to assist in their recovery.
While the ultimate insured loss won't be known for some time, the impact of these storms will be significant. And given their wide path of destruction and close timing, they will put enormous pressure on resources available for recovery. Both hurricanes also highlight the meaningful disparity between economic loss and insured loss.
According to some estimates, Helene may have the largest multiple of economic to insured loss of any U.S. storm. This protection gap imposes a meaningful burden on the economy, makes near-term recovery more challenging and undercuts resilience.
In addition, rising frequency and severity of extreme weather events, higher property values, and increased development in cat-prone areas are driving the need for greater protection. We and the insurance industry help communities, businesses, and governments build resilience to manage these perils.
But as these storms highlight, there is opportunity to do more through risk mitigation, event preparedness and alternative solutions such as community-based Parametric products.
Turning to our results. The third quarter marked another milestone for Marsh McLennan, we continue to perform well across our business, and we were thrilled to announce the acquisition of McGriff Insurance Services. In the quarter, we generated 5% underlying revenue growth following 10% in the third quarter of last year, reflecting solid execution in RIS and Consulting.
We grew adjusted operating income 12%. Our adjusted operating margin expanded 110 basis points, adjusted EPS grew 4% or 11%, excluding a discrete tax benefit in the third quarter of last year, and we completed $300 million of share repurchases in the quarter.
Turning to McGriff. It is a leading provider of insurance broking and risk management services in the U.S. with approximately $1.3 billion in revenue. I have long admired McGriff. They have excellent leadership, talented colleagues and a track record of strong growth. Their deep specialty and industry capabilities will strengthen the value proposition and expand the reach of Marsh McLennan agency in the vast and growing middle market segment. McGriff focus, culture of collaboration and commitment to excellence and integrity mirror our own.
Together, McGriff and MMA will create new opportunities for colleagues to be their best and helping them deliver even greater value to clients. The $7.75 billion transaction will be funded by cash on hand and debt financing. We expect to close by year-end, subject to regulatory approval. We would also expect the transaction to be modestly accretive to adjusted EPS, excluding amortization in year 1 and become more meaningfully accretive in year 2 and beyond.
We have a terrific track record of acquiring and integrating businesses, and we are excited to welcome McGriff's over 3,500 colleagues to the company when the deal closes. McGriff has added to what is already an active year for M&A across our business. We are on track record for the largest M&A year in Marsh McLennan's history, with nearly $10 billion of capital committed to acquisitions year-to-date, including McGriff, Vanguard's U.S. OCIO business, Cardano, Horton and FBBI. These acquisitions highlight our strategy to deploy capital to faster-growing segments of our business.
As we have said before, we consistently focus on delivering in the near term while investing for sustained growth over the long term. Shifting to the macro environment. The overall backdrop remains supportive of growth despite what continues to be a complex and volatile landscape.
Central banks have begun a cycle of easing and consensus views of the likelihood of near-term recession for most major economies are well below where they were coming into the year. We continue to see economic growth across most of our major markets. Inflation remains elevated, but declining. Labor markets remain healthy and the cost of risk in health care continue to rise.
That said, uncertainty remains with rising geopolitical tensions and continuing conflicts in Ukraine and the Middle East. Clients across the world continue to assess the implications of technology advances and AI, the ever-persistent threat from cyber attacks, supply chain risk, and the impact of increasing frequency and severity of extreme weather events on their businesses.
Our talent, expertise and solutions help clients manage challenges and accelerate opportunities to thrive. So we remain positive in our outlook for growth. We are well positioned and have a track record of performing across economic cycles due to the enduring value we bring to clients and the resilience of our business.
Turning to insurance and reinsurance market conditions. The Marsh Global Insurance Market Index was down 1% overall in the third quarter versus flat in the second quarter. Rates in the U.S. and Latin America were up low single digits, Europe was flat. And in the U.K., Asia and Pacific, rates were down mid-single digits.
Global property rates were down 2% versus flat in the second quarter. However, global casualty rates increased 6% with U.S. excess casualty up approximately 20% in the quarter.
Workers' compensation decreased low single digits. Global financial and professional liability rates were down 7%, while cyber decreased 6%. In reinsurance, demand continued to rise and capacity remained adequate in the quarter. While it is too early to know the ultimate insured losses from Hurricanes Helene and Milton, we expect there to be an impact on 2025 property insurance and reinsurance pricing.
Cat bonds, which posted record volume in the first half, remain likely to have elevated issuance activity through year-end driven by a heavy maturity schedule. And capacity for casualty programs is expected to be adequate despite concerns over the pace of loss cost inflation.
As always, we are helping clients navigate these dynamic market conditions. Now let me turn to our third quarter financial performance. We generated adjusted EPS of $1.63, which is up 4% from a year ago or 11%, excluding a $0.10 discrete tax benefit in the third quarter of last year.
On an underlying basis, revenue grew 5%. Underlying revenue grew 6% in RIS and 4% in Consulting. Marsh was up 7%,, Guy Carpenter 7%; Mercer 5% and Oliver Wyman grew 1%. Overall, in the third quarter, adjusted operating income grew 12%. And our adjusted operating margin expanded 110 basis points year-over-year.
For the 9 months, consolidated revenue grew 7% on an underlying basis. Adjusted operating income grew 12% and our adjusted operating margin expanded 110 basis points. Adjusted EPS was $6.93, up 10% from a year ago. Turning to our outlook. We are well positioned for another great year in 2024. We continue to expect mid-single-digit or better underlying revenue growth, another year of margin expansion and strong growth in adjusted EPS.
Our outlook assumes current macro conditions persist. However, the environment remains uncertain and the economic backdrop could be materially different than our assumptions. Overall, I'm pleased with our third quarter performance, which demonstrates execution of our strategy and continued momentum across our business.
I'm grateful to our colleagues for their focus and determination and the value they deliver to our clients, shareholders and communities.
With that, let me turn it over to Mark for a more detailed review of our results.
Thank you, John, and good morning. Our momentum continued in the third quarter with solid underlying revenue growth, significant margin expansion and 4% growth in adjusted EPS or 11%, excluding a large discrete tax benefit last year. .
Our consolidated revenue increased 6% to $5.7 billion, with underlying growth of 5%. Operating income was $1.1 billion and adjusted operating income was $1.2 billion, up 12%. Our adjusted operating margin increased 110 basis points to 22.4%. GAAP EPS was $1.51, adjusted EPS was $1.63. For the first 9 months, underlying revenue growth was 7%. Adjusted operating income grew 12% to $4.9 billion.
Our adjusted operating margin increased 110 basis points to 28% and adjusted EPS increased 10% to $6.93. Looking at Risk and Insurance Services. Third quarter revenue was $3.5 billion, up 8% from a year ago or 6% on an underlying basis. This result marks the 15th consecutive quarter of 6% or higher underlying growth in RIS, continues the best stretch of growth in 2 decades.
Fiduciary income was $138 million in the quarter. In looking ahead to the fourth quarter, we expect to see this amount decline by approximately $30 million, reflecting recent rate cuts and a seasonal drop in fiduciary assets.
Operating income in RIS increased 15% to $733 million. Adjusted operating income increased 16% to $775 million, and our adjusted operating margin expanded 130 basis points to 24.7%. For the first 9 months, revenue in RIS was $11.7 billion, with underlying growth of 8%. Adjusted operating income increased 12% to $3.7 billion, the margin increased 100 basis points to 33.6%.
At Marsh, revenue in the quarter was $2.9 billion, up 9% from a year ago or 7% on an underlying basis. This comes on top of 8% growth in the third quarter of last year. Growth in the third quarter was broad-based and reflected solid retention and new business growth.
In U.S. and Canada, underlying growth was 6% for the quarter, led by strong growth in MMA and in Vector, our MGA business. In international, underlying growth was 7% and comes on top of 10% in the third quarter of last year.
Latin America was up 8%, EMEA was up 7% and Asia Pacific was up 5%. The First 9 months of the year, Marsh's revenue was $9.2 billion, with underlying growth of 7%. U.S. and Canada grew 7% and international was up 7%. Guy Carpenter's revenue was $381 million in the quarter, up 6% or 7% on an underlying basis, driven by strong growth in international, including Global Specialties.
For the first 9 months of the year, Guy Carpenter generated $2.2 billion of revenue and 8% underlying growth. In the Consulting segment, third quarter revenue was $2.3 billion, up 3% from a year ago or 4% on an underlying basis. Consulting operating income was $462 million, and adjusted operating income was $478 million, up 7%. Our adjusted operating margin in Consulting was 21.7% in the third quarter, an increase of 90 basis points.
The first 9 months, consulting revenue was $6.7 billion with underlying growth of 5%. Adjusted operating income increased 7% to $1.3 billion, and our adjusted operating margin increased 60 basis points to 20.7%. Mercer's revenue was $1.5 billion in the quarter, up 5% on an underlying basis. This was Mercer's 14th consecutive quarter of 5% or higher underlying growth.
Health underlying growth remained strong at 8% and reflected growth across all regions. Korea grew 5%, where we saw strong growth in rewards and talent strategy. Wealth grew 4%, driven by continued demand in defined benefits consulting and growth in investment management. Our assets under management at the end of the third quarter rose to $548 billion, up significantly from the third quarter of last year and up 11% sequentially.
Year-over-year growth was driven by the impact of capital markets, our transaction with Vanguard and positive net flows. For the first 9 months of the year, revenue at Mercer was $4.3 billion with 6% underlying growth. Oliver Wyman's revenue in the quarter was $810 million, up 1% on an underlying basis. This reflects a tough comparison to 12% growth in the third quarter of last year and softness in certain geographies.
We currently see this trend extending into the fourth quarter. For the first 9 months of the year, revenue at Oliver Wyman was $2.4 billion, an increase of 5% on an underlying basis. Foreign exchange had very little impact on earnings in the third quarter. Assuming exchange rates remain at current levels, we also expect minimal FX impact in the fourth quarter.
Total noteworthy items in the quarter were $78 million. These included $54 million of restructuring costs, mostly related to the program we began in the fourth quarter of 2022, as well as some transaction-related charges. Our other net benefit credit was $68 million in the quarter. For the full year 2024, we expect our other net benefit credit will be about $270 million.
Interest expense in the third quarter was $154 million, up from $145 million in the third quarter of 2023, reflecting higher levels of debt and higher interest rates. Based on our current forecast, we expect approximately $151 million of interest expense in the fourth quarter, excluding any amounts related to the McGriff transaction.
Our adjusted effective tax rate in the third quarter was 26.7% compared with 20.5% in the third quarter of last year. Our tax rate last year included the release of a valuation allowance on foreign deferred tax assets. Excluding discrete items, our adjusted effective tax rate was approximately 26.5%. When we give forward guidance around our tax rate, we do not project discrete items, which can be positive or negative.
Based on the current environment, we expect an adjusted effective tax rate of approximately 26.5% for 2024. Turning to our McGriff transaction. McGriff is a terrific company with excellent leadership, a culture similar to MMAs, a diversified business mix, presence in faster growing U.S. markets, and a strong track record of performance. We will be paying $7.75 billion in cash consideration funded by a combination of cash on hand and new debt, and we expect to close by year-end, subject to regulatory approval.
As part of the transaction, we expect to assume a deferred tax asset valued at approximately $500 million. As we've noted in the past, we maintain considerable balance sheet flexibility to position us for this type of opportunity. We've secured a committed bridge loan facility for the full amount of the purchase price and currently plan to replace these commitments with permanent financing in the fourth quarter as we get closer to closing.
Based on our outlook today, we expect to raise $7.25 billion in new debt to fund the transaction. We value our high-quality ratings, and we were pleased that all 3 rating agencies recently affirmed our current ratings with no changes in outlook. The financial and capital management plan contemplated in the transaction is not only consistent with maintaining our current ratings, but we also expect to have meaningful flexibility for capital deployment next year.
Although initially, our leverage ratios will increase, the substantial cash flow we expect to generate as well as increased debt capacity through earnings growth will enable us to bring our leverage ratios back in line with levels necessary to maintain a strong ratings profile.
As a result, while we intend to pause share repurchases in the fourth quarter, as we think about capital management into next year, we expect we will maintain our balanced approach that includes increasing our dividend and reducing our share count each year as well as continuing to fund high-quality acquisitions.
We will obviously have more guidance around our outlook for capital deployment in 2025 on our fourth quarter earnings call early next year. As John noted, we expect the transaction will be modestly accretive to adjusted EPS, excluding amortization in year 1, becoming more meaningfully accretive in year 2 and beyond.
This transaction is a great reflection of several elements of our capital management strategy, maintaining flexibility to take advantage of opportunities, a bias to reinvest capital for growth, and delivering in the near term while challenging ourselves to invest to sustain growth into the future.
Turning to capital management and our balance sheet. We ended the quarter with total debt of $12.8 billion. Our next scheduled debt maturity is in the first quarter of 2025 with $500 million of senior notes mature. We currently expect to deploy approximately $4.2 billion of capital in 2024 across dividends, acquisitions and share repurchases, excluding the McGriff transaction.
Our cash position at the end of the third quarter was $1.8 billion. Uses of cash in the quarter totaled $1.1 billion, and included $404 million for dividends, $435 million for acquisitions and $300 million for share repurchases.
For the first 9 months, uses of cash totaled $3.3 billion included $1.1 billion for dividends, $1.3 billion for acquisitions, and $900 million for share repurchases.
I want to spend a minute on our plans to change how we report adjusted EPS. Starting next year, we will exclude the impact of acquisition-related amortization from adjusted EPS. We will also exclude the other net benefit credit, another noncash item. These changes will improve the comparability of our results and give investors a better sense of our core earnings power. It will also conform our adjusted EPS reporting with how we report adjusted operating margins.
While there continues to be uncertainty in the outlook for the global economy, we feel good about the momentum in our business and the current environment remains supportive of growth. Overall, we are well positioned for another great year in 2024. Based on our outlook today, for the full year, we continue to expect mid-single-digit or better underlying growth, margin expansion and strong growth in adjusted EPS.
With that, I'm happy to turn it back to John.
Thank you, Mark. Andrew, we're ready to begin Q&A. .
[Operator Instructions]
Our first question comes from the line of Elyse Greenspan with Wells Fargo.
My first question is on the McGriff deal. When you guys say right, that you expect it accretive to earnings less intangibles -- what are your -- can you give us some color on what your assumptions are for revenue growth relative to the $1.3 billion that you're taking on? And then also, what are you assuming for margin? I guess my question is for the year 1 guide, but any guide you kind of want to give us for year 2 and beyond would be helpful as well.
Sure, Elyse, and thank you for the question. I just want to reiterate how excited we are to bring -- welcome McGriff into the family, obviously, subject to regulatory approval. The have a really strong culture. It's a competitive group. They're so client focused. I spoke to the talent in my prepared remarks, and they'll extend our reach into -- it's a vast and fragmented middle market, they have excellent specialty capabilities, and industry focus and working together with MMA, we know they can drive better outcomes for clients, and we can create new opportunities for their colleagues as well. So we're excited about all that.
We've shared the details that we're going to share about the business like other MMA transactions, we don't disclose margins when we acquire them or for that matter, how they're growing, but we're excited about it. As I said, it will be modestly accretive in year 1 and more so after that, and we expect to earn a good return on the investment over time. So there are synergies, of course, but we're conservative in our modeling, and we're very excited about what the combination can mean.
And then my follow-up on U.S. and Canada, growth was 6% again this quarter. Can you just give us a sense of some of the dynamics that you're seeing within that market? And then relative to like the IPO and SPAC in that business, right, that's been a headwind for a couple of years, have you seen any improvement there in the quarter?
Sure. I'd start, at least, just with -- overall, I'm very pleased with our underlying growth in the quarter. I thought we had a terrific quarter. Mars, Guy Carpenter and Mercer all had terrific growth, and it was really widespread. It was across all regions and practices, and so we felt good about that. We obviously had a softer quarter of growth at Oliver Wyman.
But overall, I thought the growth was good and we're well positioned. I spoke to the macro environment, it is shifting and changing. And obviously, interest rates have begun to come down in some major economies around the world, and that's meant some new opportunity, in SPACs and IPO's and well, maybe not SPACs, but IPOs and M&A activity, we're starting to pick up a bit. But Martin, maybe you could talk a little bit about the U.S. marketplace and some of the opportunities we're seeing.
Sure, John. Thank you. As you said, very pleased with underlying growth of 7%, which is kind of in line with 8% in 3Q, '23 and 3Q '22, very good balance of growth across international and in the U.S., but I'll double-click a little bit on the U.S. performed very well, 6% on top of 6% in Q3. We saw very good growth from MMA and Vector. And to Elyse question, we did see double-digit growth in the capital markets and MMA products. Construction & Aviation performed well and globally, very strong growth in our benefits business as well. So overall, pleased with that, good momentum and expect that to continue.
Double-digit growth, at least in capital markets, of course, is off a lower base, right, after a couple of years of a soft environment there. So thank you for your questions. .
Our next question comes from the line of Jimmy Bhullar with JPMorgan. .
So first, I just had a question following up on your comments on Milton and its impact on the market. So just specifically on reinsurance. Just wondering what your expectations are on how Milton affects renewals? And should one assume that prices could actually go up or they're just going to go down given the high loss.
Yes. I think, Jimmy, at the end of the day, it's too early to know that at this point. There's obviously a range of estimates out there and the ranges are quite wide. And so there's still a lot for us to learn, many property owners are just getting to their facilities at this point. And so I spoke about the overall economic impact to the Southeast and what it means to those communities at a human level as well, it's going to be a challenging recovery, and it's going to extend for a bit of period of time.
Maybe I could ask Dean to comment a little bit about where we're expecting in advance of those storms? And any thoughts he has on the impact it might have. Dean?
Yes. Thanks, John. And Jimmy, as we entered the kind of fall conference season ahead of Helen and Milton, I think our clients, and we anticipated a very competitive market environment at the upcoming January 1 property cat renewal. I think post Milton, it's still early, but I think we see a flattening of pricing in the property cat market at the upcoming January 1 renewal.
If you think about kind of lower and mid-level layers and programs, we kind of see risk-adjusted flattish at this point without all the data in, and you could still see some softening, some rate reductions in more remote risk layers and property cat towers. As John said, keep in mind, it's early. We're still in wind season. There could be additional CAT events over the next several weeks that would shape the market.
And as John noted, it will be several weeks before we have sufficient claims data to make accurate loss estimates and those impacts on our clients. And right now, we're just relying on all of our cat modeling partners to come up with some of those estimates.
But to sum it up, Jimmy, I would say, overall, property cat demand should increase at January 1 from our clients. We think capacity in the marketplace will be adequate. We think the renewal will be manageable for most of our clients. The market is well capitalized to trade forward and meet client demand.
And keep in mind, I think the headline, Jimmy, is the major of the cat losses this year will be borne by our clients given the high entachment points that were imposed on that after Hurricane Ian 2 years ago.
Dean, Jimmy, do you have a follow-up?
Yes. Just on Oliver Wyman. Obviously, the comps were tough as well, but you noted seeing weakness in some geographic regions. Was that a function of the economy? Or is there something else that's affecting results in the areas that you mentioned.
Yes, sure. 1%, obviously, underlying was softer than we'd planned for. It was a tough comp, and we're up 5% year-to-date. And what I would also say is, I mentioned to you in the past, there's going to be more volatility quarter-to-quarter at Oliver Wyman. We do expect higher underlying revenue growth from Oliver Wyman over the medium to long term. But Nick, maybe you could share some insights on what you're seeing in the market. .
Thank you, Jimmy. We often say this is a mid- to high single-digit business through the cycle. And I think it's fair to say we're at a low point in the cycle. And we've talked for a few quarters now about that being a tough market, and we do see that continuing. Maybe at a macro level, I'd just note, we're more than 50% larger than we were prepandemic. We're 2/3 larger than that pandemic year. And I think we are consolidating those gains in that tough market. But for the quarter itself, no 1 likes a one, no 1 likes a 1 following a 3. They were at 12 and 11 comp. Thank you for noting that in the question. When we look at the year as a whole, we're 5, I think I do want to note we're on the front foot inorganically as well because there are parts of our business where scale does matter. And so the business is 8% larger than in the same periods first 3 quarters of last year. And that represents a form of progress.
We've seen very strong growth in Asia and the Pacific region, bouncing back from a tougher period, our India, Middle East and Africa business continues to grow. The regional softness has been more in the Americas and in Europe. I think some of that is linked to the economy, but also just corporate buying habits given uncertainty in the Americas, maybe in the U.S., particularly some waiting for the election.
Sector-wise, our best growth has been in our communications, media and technology practice. Our insurance and asset management practice growing very strongly. Automotive and manufacturing doing well, and our large banking practice continuing to be pretty robust. But overall, we see it as being a relatively tough market, which we'll continue to work our way through.
Thank you, Jim, for your questions. .
Our next question comes from the line of Greg Peters with Raymond James.
I guess for my first question, I'd like to focus on the free cash flow results. I was looking in the statement of cash flows, operating cash flow through the 9 months, down a little bit, not growing in line with revenue. And just -- I'm sure there's some puts and takes in there. Just some color there would be helpful.
Yes. Sure, Greg. As we've noted in the past, there's going to be more volatility to free cash flow growth, certainly than our earnings growth. But Mark, maybe you could share some color.
Yes, just I'll repeat that, John. We -- free cash flow is something that is volatile quarter-to-quarter and year-to-year. So best looked at over long stretches of time. Our track record in free cash flow growth, as we've noted before, has been terrific. So we're a double-digit free cash flow growth for a decade plus. And that's what you'd expect for a company that's grown its EPS double digits given our high cash generation capital type model.
There's no story in the results year-to-date. So free cash flow is down. Dewas up 28% last year. It was actually up in the third quarter. So what you're seeing year-to-date is just a number of factors that caused this period-to-period volatility. So we had higher variable compensation payouts in the first quarter because of our strong results last year. Receivables are up because of growth and it's just a little bit of business mix and timing. And there's just a handful of one-timers in last year's period, this period that affect the year-over-year comparison. So overall, we have an outlook for continued strong growth in earnings, and therefore, our free cash flow growth into the future should be strong as well.
Thanks, Mark. Greg, do you have a follow-up? .
Yes. Mark, in your comments, I think you mentioned something about fiduciary income and interest income and you provided some guidance. And I'm wondering if you could just -- you guys are flying through so many comments. If you could just revisit those comments and sort of -- I think you're framing it for fourth quarter. And if we could push it out and sort of frame it for next year or 2 for us would be helpful. .
Yes, sure. Let me repeat what I said. We did have a lot in the script this quarter. So we just wanted to flag that as we look into the fourth quarter, we typically see, especially in Guy Carpenter, just given the seasonality of their revenue with so much activity in the first half, we do see fiduciary balances that tend to fall off in the fourth quarter. So we do expect fiduciary income to be $30 million or so lower in the fourth quarter from the level we saw in the third quarter. And it's a combination of the rate cuts that have happened and the impact that they will have as well as the seasonal drop in fiduciary balances.
We look out to 2025, it's really going to depend on what rate actions happen from here. What happens in the balance of this year, what happens since the next year. And so we're going to stay away from speculating there, but just to repeat some of the things we've said in the past. The math is pretty straightforward.
So we've got roughly $11.5 billion of balances on average these days. And so you can use that as a basis to try to do some sensitivity analysis around what that could mean to fiduciary income. There would be some offsets. There are -- there is some interplay with some of our variable compensation programs. We obviously would pay less in terms of interest on short-term debt. But we'll just have to wait and see what happens with further cuts as we look into next year.
Greg, I would just add, we're accustomed to operating in a lower rate environment. So we'll adjust our plans accordingly. I will likely be an increasing headwind for us into 2025. And we model out the various scenarios, not just from this headwind, but from other headwinds as well. And so we make plans accordingly. But a lower rate environment could also or likely will impact other parts of our business as well.
We touched on increasing transaction risk as a result of higher volume in M&A markets, IPOs, construction, Mercer Wealth, of course, overall, our cost of capital, will be impacted as well. So there'll be lots of ins and outs from a lower rate environment, and we're working our way through all those issues.
Thank you, Greg.
Next question comes from the line of Mike Zaremski with BMO Capital Markets.
First question on the -- thanks for the update on the Marsh pricing index, which moved to negative 1 territory, I believe. Can you help tease out how this index and kind of pricing in this marketplace is having an impact on Marsh's organic growth? I know that there's an element of fees and then commissions as well. But is this -- is the index as it's decelerated in the last year or so, has it had any material impact on your Marsh's rate of organic growth?
Look, first of all, Mike, what I would say is that the markets overall, on average, are stable. Insurers have picked up quite a bit of price over the course of the last several years. So minus 1 was some welcome relief, at least for many of our clients at Marsh after what's been a tough pricing environment. Of course, price is ultimately a reflection of the cost of risk over time. And so as I mentioned in my prepared remarks, the cost of risk continues to escalate. .
About half of our business at Marsh is sensitive to our revenue. That is a sensitive to P&C pricing through commission. The rest of it, of course, is on a fee. And it's not a direct line. You have buying habits change as markets soften a bit and the risk environment changes. You may have clients retain less risk than they had over the course of the last few years.
We've talked on prior calls, for example, about the growth in our captives business, the premium and the captives that we manage have been growing faster than the premiums that we see into the marketplace. If the market continues to get a bit more competitive, that may change. So obviously, it has an impact, but it's not a straight line from price.
What I would also point out to you is that our index is skewed to large accounts and that the middle market pricing is more stable, and it's up low to mid-single digits. I hope that's helpful. Do you have a follow-up?
Yes, a quick follow-up. I'll stick with your pricing commentary. Hopefully, other people asked about Mercer Health being strong. But so U.S., I believe, you said was plus 20, that's a pretty big number. Maybe you can talk about whether there's dislocation in that marketplace? Or what's going on? Is it going to be moved to the E&S market? Or maybe that's not even in maybe just anything -- any color you could add that seems like that's a number that's distressed for certain some of your clients.
Yes. I'm sure, Mike, on the last call, in fact, I talked about some real troubling signs in the U.S. liability market. Maybe I'll ask Martin to share some insights on what we're seeing in that marketplace.
Yes. Thank you, John I'll just start with a comment that overall, the composite rating index is up about 1.5x since 2012. The casualty book is up 6% in North America with the excess book up 21%. At the moment, we're not seeing dislocations in that the capacity that clients are requesting we can place, there are smaller limits that insurers have, and we're doing jobs to think what we can do to place quota share programs for our clients to avoid compression of limits. .
And so we don't see anything too sinister in terms of supply for clients at this point. Certainly, there's been a movement to the E&S market, and we're big players in that space. And that segment of the market has grown significantly. There's more agility and rate movement in those areas there. So we're well positioned to help them with that, and we're continuing to work with them as our clients deal with some of the social inflation that we've talked about in the past as well. So lots of other services that we need to wrap around that to help our clients navigate this market. .
Thank you, Mike, and thank you, Martin. .
Our next question comes from the line of Brian Meredith with UBS.
First one for Dean on the reinsurance side. You mentioned that you expect ample capacity in the casualty lines. I'm just curious, can you maybe talk a little bit about how are the reinsurers do you think going to be reacting to this tort inflation that we continue to see in the marketplace at 1/1? Do you think -- we'll see a lot of tightening in terms and conditions. What are you hearing? What are you seeing from them?
Yes. Thanks, Brian. I'll hand it to Dean in a second, but loss cost inflation in casualty lines remains a real challenge for the marketplace overall, and we're concerned about it from our clients' perspective, and was the talk of conference season, I think in advance of Helene and Milton. So Dean, maybe you could share some thoughts on what you're seeing in reinsurance casualty. .
Yes. Thanks, John. And Brian, as John said, I think reinsurers generally continue to express great concern about the U.S. casualty reinsurance market focused, in particular, on excess casualty as noted by John and Martin for all the factors we've been discussing. That said, as we head to the 1/1 renewal season, we think current market conditions will largely prevail in the casualty market at 1/1, that said, we continue to see downward pressure on ceding commissions for quota share deals averaging 100 basis points.
Therefore, that's a rate increase, excess of loss contracts, more robust rate increases in the 5% to 25% range and maybe many structural changes to get those deals across the line. We do expect adequate capacity in the marketplace, maybe more limited for XOL deals. Thus far, these deals are challenging, but they're getting done, they're getting across the line in the marketplace. And I really think the key for our clients, as Martin and John have said, is going to be the performance of their underlying portfolios. Are they getting underlying rate increases in their books? Are they managing limits in excess casualty and other lines that will be the key formula for successful for renewal. But casualty is challenging right now in the market, but we think it's stable and most deals will get done. .
So clear signs of loss cost inflation, loss development patterns disrupted by the impact of the economy and closing of courts during the pandemic and then kind of the economic rebound. So it's challenging for all of us to get our arms around it. And we're obviously doing our best to help clients navigate the uncertainty around it. .
Brian, do you have a follow-up?
Yes, absolutely, John. And I know we've talked about this before, but maybe just your perspective on the business continuing to flow to the non-admitted market. Do you think that's slowing here? And then also, how can Marsh kind of react to that to mitigate that or maybe recapture share? And does McGriff have anything that could potentially help you benefit you in the non-admitted area? .
To be clear, we're not losing share as a result of the growth in the E&S market in the United States, you're seeing -- you have seen and observed outsized growth in wholesale broking as a result of that. But we have access to those markets, and we'll access that capital if it's the right solution for our clients. Generally, we prefer admitted solutions for our clients given kind of what comes with being an admitted insurer.
So our strategy is about accessing as much of the market directly, including E&S insurers as possible. And overwhelmingly, the E&S premium that we place into the market today, we do directly today, right? So to be clear. In terms of market growth, future market growth, it's hard to say, but -- and I certainly understand in this dynamic risk environment, certainly multichannel insurers that have both admitted and non-admitted, why they want to use more nonadmitted solutions, it gives them more flexibility to react more quickly to the changing risk environment.
So I understand that. Again, our focus is accessing capital as directly as possible and as efficiently as possible so we can continue to drive the best solutions for our clients. We'll continue to use wholesale brokers, but for niche expertise where they serve us and our client well. So anyway, that's really how we see it, Brian.
Our next question comes from the line of Grace Carter with Bank of America. .
Hi, everyone. I was hoping to ask a couple of cleanup questions regarding McGriff. Is there any possibility that you all might give us some of the below-the-line impacts like how much you're thinking amortization might increase associated with the deal. And any sort of transaction or integration expenses that we should expect over the next few quarters?
Grace, thanks for the question. No, we're not prepared to do that. As I said, it's typical MMA transactions. So we haven't disclosed margins or the underlying performance of the businesses other than I will say, we're very impressed with the performance of McGriff. It's had strong underlying revenue growth. Sales velocity is quite strong as well, very similar to the performance of MMA. .
And I guess on the tax rate, I know it's a bit early to be looking at next year, but just kind of considering how the geographic mix of the business might be impacted by the deal. I mean is kind of the 25% to 26.5% original guide for this year still kind of fair to assume. And while we're on the subject of tax, if you could help us maybe think about the time line for utilizing the DTA that you're getting? .
We're not going to guide to 2025. We'll talk about that in January on the call. So Mark, anything else to share on tax overall?
Just to your question on the deferred tax assets. So the value I talked about is the present value of the future tax deduction stream that we affect and that is going to go out over a long period of time.
Thank you. Thank you, Grace. And next question, please? .
Our next question comes from the line of Rob Cox with Goldman Sachs.
Appreciate that it's the largest MMA year in MMC's history. I'm curious if the price you're paying for top 100 brokers has changed your thought process at all on relative capital deployment across the different avenues.
Look, we've talked about our approach to capital management. We favor investing in the business over buybacks. We as you know, aspire to be -- to raise our dividend each and every year as well. We have a responsibility, obviously, to be good stewards of our capital. So we are -- although multiples have increased over the course of the last several years, we have great confidence in our ability to earn a return well in excess of our cost of capital. And so should that change or should we see a deal that doesn't accomplish those objectives.
We'll deploy capital elsewhere. But we have a very strong reputation as a buyer in the marketplace. We spend a lot of time game planning various scenarios from small to midsized kind of tuck-in store business to more material deals like McGriff and we're very well positioned in that marketplace. Mark talked about even after McGriff, we maintain a lot of flexibility if we see the opportunity to make -- not make ourselves not just bigger but better as a business going forward. So that's our approach. Do you have a follow-up, Rob?
Yes. Thanks, John. Yes, I just wanted to ask a question on something that I feel like doesn't get a lot of airtime, but I was hoping to get an update on the commission rates and fee rates in the brokerage operations. Is there anything you can tell us about how these take rates have changed over the course of the hard market in recent years? And if not, what's driving the stability? .
I actually -- I don't view the last several years as a hard market, right? Just to start with that. I thought what we observed as challenging it was for our retail clients, at Marsh was largely kind of a catch-up period for insurers on average to catch up with the accelerating loss cost. Not to say certain markets in a shorter period of time, were challenging.
For example, when ransomware picked up in the cyber market and the underwriting community have not really priced for that kind of risk, the market jumped pretty quickly, but then it settled quite quickly as well. And in fact, the market is coming back in favor of our retail clients a bit at the moment. So I would start with that. But over a fairly extended period of time, our average commission rates at Marsh have remained fairly stable. From product line to product line, there's some movement, but for the most part, average acquisition expense through Marsh has been pretty constant. Thank you, Rob, for your questions. Andrew, another question, please?
Our next question comes from the line of Andrew Kligerman with TD Cowen.
Excellent. I made it. John, Mark, your underlying growth in RIS is nothing shy of outstanding. And we looked last year at double-digit underlying growth this year, it's kind of decelerated down to 6%, which is still excellent, but the question for you going forward, and I know you guide to mid-single digit or better underlying growth across businesses. So what kind of gives you the confidence that it kind of holds in this kind of zone, maybe even slightly less and doesn't decelerate further?
Thank you, Andrew. We always have time for you, Andrew, just to be clear. Look, as I mentioned in our -- in my prepared remarks, the macro environment remains supportive of growth, but we're in this elevated risk environment, geopolitical risk, frequency and severity of weather, cyber events, loss cost inflation, all those things creating opportunities for us to help clients. And pricing has moderated, but markets have been disciplined overall. .
And we've been very focused on building and adding to our capabilities, right? And McGriff is kind of the latest example of that. We're investing organically and inorganically. We've been reshaping the mix of our business over time, right? So McGriff is another example of deploying capital into the faster-growing middle market.
I would also note that we're working together better than we ever have as well. That's driving some real growth opportunities for us as well. So again, we'll guide around 2025 in January. But I feel like we're executing well and in this elevated risk environment. There's real opportunities for us to continue to drive good growth in our business. .
Got it. And you just touched on the faster growth in MMA. Any color, John, that you could provide around how much it outpaces large corporate business. .
Yes. I mean we're not going to disclose kind of segment growth, but it is higher. It's over time. And by the way, not in every quarter and in every year for that matter over the course of the last several years has it outpaced the upmarket growth at Marsh, but it's been a more consistent growth business for us. And what really excites me about that marketplace is how we can bring scale benefits to clients really at a different level.
So -- and I think McGriff is a great example. It's a terrific business with outstanding fundamentals, terrific leadership outstanding talent all throughout its business. And we've shown, and as we've brought firms into MMA, we can make them even stronger. We can bring capabilities from MMA and Marsh to help them better serve clients. So we are excited about that.
So thank you. Andrew, I appreciate the questions. And Andrew, I think we'll wrap up the call at this point given that we're having a fire alarm in our building. So I want to thank you all for joining us on the call.
In closing, I want to thank our colleagues for their hard work and dedication. I also want to thank our clients for their continued support. So thank you all, and we look forward to speaking with you again next quarter.
Ladies and gentlemen, thank you for participating. This does conclude today's program, and you may now disconnect.